Abstracting and Indexing

  • PubMed NLM
  • Google Scholar
  • Semantic Scholar
  • Scilit
  • CrossRef
  • WorldCat
  • ResearchGate
  • Academic Keys
  • DRJI
  • Microsoft Academic
  • Academia.edu
  • OpenAIRE
  • Scribd
  • Baidu Scholar

Endobronchial Tuberculosis: from Diagnosis to Management and Quality of Life- A Case Report

Author(s): Teodora Butnaru, Florin Dumitru Mih?l?an, Adam Andrei, Diana Cocuz, Ancu?a Alina Constantin

Despite rapid advances in diagnostic and treatment modalities, endobronchial tuberculosis (EBTB), the particular form of tuberculosis defined as infection of the tracheobronchial tree caused by Mycobacterium tuberculosis, continues to remain a challenge for clinicians. Non-specific respiratory symptoms as well as normal radiological appearance (10-20% of cases) can be invoked for the delay in diagnosis. The bacteriological examination of the sputum smear has a low diagnostic yield. The positivity of the sputum smear varies between 16 and 53%, so a negative result does not exclude the diagnosis. In such cases, high-resolution computed tomography (HRCT) functions as a more sensitive tool and demonstrates the involvement of the tracheobronchial tree classically described as "tree-in-bud" appearance. Bronchoscopic biopsy is considered the most reliable method of confirming the diagnosis with a yield of 30% to 84%. The evolution of the disease is unpredictable, with a frequent progression to bronchial stenosis, therefore it requires regular follow-up and early intervention. The quality of life of patients with EBTB is affected both because of the debilitating symptoms and the side effects of treatment. Tracheobronchial stenosis, a common complication, can turn patients into chronic sources of infection or cause serious pulmonary complications. In this context, we present the clinical case of a 40-year-old patient with persistent cough syndrome, diagnosed with endobronchial tuberculosis by bronchoscopy, later confirmed by positive cultures for Mycobacterium tuberculosis. Treatment included the standard treatment regimen, adjusted to manage adverse reactions. This case highlights the importance of early diagnosis and appropriate management to improve quality of life and reduce EBTB-associated morbidity.

Journal Statistics

Impact Factor: * 3.5

Acceptance Rate: 71.36%

Time to first decision: 10.4 days

Time from article received to acceptance: 2-3 weeks

Discover More: Recent Articles

Grant Support Articles

    Editor In Chief

    Masashi Emoto

  • Professor of Laboratory of Immunology
    Department of Laboratory Sciences
    Gunma University Graduate School of Health Sciences
    Gunma, Japan

© 2016-2025, Copyrights Fortune Journals. All Rights Reserved!